Creative Medical Technology Holdings, Inc. Current Liabilities
Creative Medical Technology Holdings, Inc. (CELZ) had Current Liabilities of $698.60 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $698.60K.
- 2026-03-31: Liabilities, Current $307.65K.
- 2025-12-31: Liabilities, Current $284.88K.
- 2025-09-30: Liabilities, Current $261.35K.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $698.60K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $307.65K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $284.88K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $261.35K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $277.64K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $286.39K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $327.64K 10-K · filed 2026-03-20 | |
| 2024-09-30 | $330.91K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $376.27K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $390.96K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $371.39K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $421.16K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $398.53K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $407.54K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.32M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $396.96K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $389.80K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $379.80K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.05M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.50M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $3.31M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $40.52M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $3.20M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $4.65M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.65M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $8.60M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $3.89M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.00M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $4.18M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $4.47M 10-K · filed 2020-04-06 | |
| 2018-09-30 | $7.71M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $10.87M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.22M 10-Q · filed 2018-08-03 | |
| 2017-12-31 | $2.44M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $1.27M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.31M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $468.87K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $453.86K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $445.96K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $304.02K 10-Q · filed 2016-08-19 | |
| 2015-12-31 | $100.00 10-K · filed 2017-02-13 | $157.82K 10-K · filed 2016-04-14 |
| 2015-03-31 | $162.90K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $154.00K 10-K · filed 2016-04-14 | |
| 2014-09-30 | $147.83K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $142.08K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $136.34K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $125.41K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $119.38K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $113.94K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $109.58K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $99.32K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $92.91K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $86.78K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $82.85K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $75.27K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $69.57K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $61.16K 10-Q/A · filed 2011-08-25 | |
| 2010-12-31 | $48.52K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |